OmniAb, Inc.

US$5.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OABIHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (7.05%)
Div yield —
ROE (16.51%)
Biotechnology
Beta (5Y) 1.36
PE TTM —
TSR TTM 224.52%
Mkt cap US$733.7M
ROIC (8.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.43
27.84%
(87.32%)
Hold 4|10|2|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.08
0.08
26.93%
33.14%
18.61%
23.45%
Revenue$M
45.25
44.46
44.63
46.16
10.77%
7.48%
3.12%
3.00%
Peers (US$733.7M)
Cap (US$)
PE
724.0M
—
740.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.993
(0.067)
(0.081)
EBIT/Intx
4.562
0.112
0.115
Own earn%
(44.89)
20.45
35.08
Sh yield%
25.59
26.17
26.58
Owners
Insiders/Inst%
11.22
29.57
Short interest%
4.23
SBC / revenue%
5.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
10–20
$1 testx
—
Incr. ROIC%
7